HA155

CAS No. 1312201-00-5

HA155( CS-963 )

Catalog No. M26244 CAS No. 1312201-00-5

HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
5MG 65 In Stock
10MG 103 In Stock
25MG 211 In Stock
50MG 332 In Stock
100MG 491 In Stock
200MG 702 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HA155
  • Note
    Research use only, not for human use.
  • Brief Description
    HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.
  • Description
    HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.(In Vitro):HA155 completely attenuates the thrombin-mediated increase in platelet-derived LPA dose-dependently .HA155 is an ATX inhibitor by binding to the ATX active site .
  • In Vitro
    HA-155 inhibits ATX by binding to the ATX active site.HA155 completely attenuates the thrombin-mediated increase in platelet-derived LPA in a dose-dependent manner.
  • In Vivo
    ——
  • Synonyms
    CS-963
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1312201-00-5
  • Formula Weight
    463.29
  • Molecular Formula
    C24H19BFNO5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (21.58 mM)
  • SMILES
    O=C1N(CC2=CC=C(F)C=C2)C(S/C1=C\C3=CC=C(OCC4=CC=C(B(O)O)C=C4)C=C3)=O.[(Z)]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Guo B, et al. Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis. Clin Ther. 2017 Jul;39(7):1336-1346.
molnova catalog
related products
  • BAY 2666605

    BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.

  • MBCQ

    MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.

  • BI-409306

    BI-409306 is a potent and selective inhibitor of PDE9A (IC50 of 52 nM),and can be used in the research of memory.